Browse studies

Find your next paid study

1,574 recruiting studies matching your filters

Pulse Field Ablation for Post-Infarction Ventricular Tachycardia: the ASCEND Pilot Study

ASCEND is a randomized controlled open-label pilot study evaluating the safety and effectiveness of pulsed field ablation (PFA) with the novel FARAPOINT cathet…

Ventricular TachycardiaIschemic Heart DiseaseSustained VT

Estimated

~$10 – $7,500

Pasquale SantangeliNCT06891456

Orthopaedic Data Bank; Collection and Storage of Data Relating to Orthopaedic Disorders

Data involving orthopaedic conditions and rehabilitation aspects of musculoskeletal and neuromuscular disorders will be collected and stored as part of the nor…

OsteoarthritisOsteosarcomaScoliosis+1 more

Estimated

~$10 – $750

University of FloridaNCT00411060

Natural History of Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment

Background: In Fontan Associated Liver Disease (FALD), congestion of blood in the liver causes cirrhosis. This condition can cause death. Researchers want to …

Congenital Heart Disease

Estimated

~$10 – $675

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT05213598

A Prospective, Single-Center Study to Test the AdaptDx Pro Agreement in Rod Intercept Time With the AdaptDx in Healthy Subjects With Normal Vision (FlashBack)

The purpose of this study is to test the AdaptDx Pro agreement in Rod Intercept (RI) time with the AdaptDx tabletop (AdaptDx) in healthy subjects with normal v…

Healthy Adult Participants

Estimated

~$10 – $1,050

AdaptDx, Inc.NCT07803588

Phase 1

Alpelisib Challenge Test (ACT) for Assessment of Pancreatic β-Cell Reserve, Pilot & Feasibility Study

The goal of this study is to test a potentially easier method for measuring how much insulin a person is capable of producing than the current gold-standard me…

Insulin ResistanceType 2 DiabetesObesity & Overweight+1 more

Estimated

~$10 – $6,250

Columbia UniversityNCT07778524

Observational

Right Ventricular Pacing to Treat Right Ventricular Failure: A Single Arm Hemodynamic Study

In pulmonary arterial hypertension (PAH), progressive pulmonary vascular remodeling leads to supraphysiologic right ventricular (RV) afterload. Pharmacologic t…

Pulmonary Artery HypertensionRight Ventricular Dysfunction

Estimated

~$10 – $5,625

University of California, San FranciscoNCT04194632

Observational

Multicenter Pivotal Study of the Velocity™ Percutaneous Arterio-Venous Fistula System

This study will evaluate the Velocity Percutaneous Arteriovenous Fistula (pAVF) System, a new minimally invasive method for creating dialysis access. People wi…

Chronic Kidney DiseaseHemodialysis AccessArteriovenous Fistula+1 more

Estimated

~$10 – $7,500

Venova MedicalNCT07153939

Observational

Remote Dielectric Sensing Technology Guided Diuresis in Hospitalized Patients With Acute Decompensated Heart Failure

This study evaluates the use of a wearable vest capable of non-invasively measuring lung fluid content in hospitalized patients with heart failure

Heart Failure; With Decompensation

Estimated

~$10 – $5,625

University of California, San FranciscoNCT03586336

Phase 1

An Open-Label, Multicenter, Phase 1/2 Dose-Escalation and Expansion Trial Evaluating the Safety and Efficacy of FT839 in Participants With Autoimmune Diseases

The primary objectives of this trial are to evaluate the safety and tolerability and to determine the maximum tolerated dose (MTD) or recommended Phase 2 dose …

ANCA-Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Rheumatoid Arthritis (RA)+2 more

Estimated

~$10 – $8,750

Fate TherapeuticsNCT07800871

Phase 3

An Adaptive, 2-Part, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of IKT-001 in Pulmonary Arterial Hypertension (PAH)

This is an adaptive, 2-part, randomized, multicenter, double-blind, placebo-controlled, parallel-group study designed to evaluate the efficacy and safety of IK…

Pulmonary Arterial Hypertension

Estimated

~$10 – $8,750

Inhibikase TherapeuticsNCT07365332

Observational

Impact of Peanuts on Cardiometabolic, Cognitive, and Intestinal Health in Prediabetes Among Racially Diverse Populations

The overall objective of this 14-month randomized crossover study is to seek evidence demonstrating that daily consumption of peanuts and peanut products impro…

PrediabetesPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Cognition+5 more

Estimated

~$10 – $6,250

Georgia State UniversityNCT06867198

Phase 1

Open-label, Phase 1b, Single Ascending Dose Study to Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial Hypercholesterolemia or Premature Coronary Artery Disease Who Require Additional Lowering of Low-density Lipoprotein Cholesterol

VT-10201 is an Open-label, Phase 1b, Single-ascending Dose Study That Will Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial…

Heterozygous Familial HypercholesterolemiaPremature Coronary Heart Disease

Estimated

~$10 – $8,750

Verve Therapeutics, Inc.NCT06164730